异位分泌促肾上腺皮质激素和/或促肾上腺皮质激素释放激素的嗜铬细胞瘤
该系统综述通过检索PubMed/MEDLINE和Web of Science(截至2020年2月10日),纳入91篇文章共99例异位分泌促肾上腺皮质激素和/或促肾上腺皮质激素释放激素的嗜铬细胞瘤患者,中位诊断年龄49岁,女男比2:1,多数表现为临床库欣综合征、高血压和/或糖尿病,术后多数患者血压、血糖及生化指标改善,感染为最常见并发症。
要点
- 异位分泌促肾上腺皮质激素和/或促肾上腺皮质激素释放激素的嗜铬细胞瘤患者中,81%出现临床库欣综合征,93%有高血压,54%有糖尿病。
- 术后绝大多数患者血压、血糖控制及生化参数改善,感染为最常见并发症。
- 有长期结局资料的70例(88%)患者至发表时存活,中位随访6个月。
核心结论
- 对于表现为促肾上腺皮质激素依赖性库欣综合征和肾上腺肿块的患者,应考虑异位分泌促肾上腺皮质激素和/或促肾上腺皮质激素释放激素的嗜铬细胞瘤。
- 尽管诊断具有挑战性,但患者结局似乎良好。
研究设计与样本
- 系统检索PubMed/MEDLINE和Web of Science,纳入截至2020年2月10日发表的原始文章,包括病例报告和病例系列,报告异位分泌促肾上腺皮质激素和/或促肾上腺皮质激素释放激素的嗜铬细胞瘤患者的个体数据。
- 共纳入91篇文章,报告99例异位分泌促肾上腺皮质激素和/或促肾上腺皮质激素释放激素的嗜铬细胞瘤患者(其中分泌促肾上腺皮质激素释放激素者4例)。
主要发现
- 诊断时中位年龄49岁(四分位距38-59.5),女性与男性比例为2:1。
- 大多数患者表现为临床库欣综合征(79例,81%)、高血压(87例,93%)和/或糖尿病(50例,54%)。
- 术后绝大多数患者血压、血糖控制及生化参数改善。
- 感染是最常见的并发症。
- 有长期结局报告的多数病例(70例,88%)至发表时存活(中位随访6个月)。
临床怎么用
- 对于表现为促肾上腺皮质激素依赖性库欣综合征和肾上腺肿块的患者,应考虑异位分泌促肾上腺皮质激素和/或促肾上腺皮质激素释放激素的嗜铬细胞瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The characteristics of catecholamine-secreting pheochromocytomas have been well studied. However, less is known about the characteristics, management and outcome in patients with ectopic adrenocorticotropic hormone (ACTH) and/or corticotrophin-releasing hormone (CRH)-secreting pheochromocytomas. OBJECTIVE: To review the characteristics and outcomes of ACTH- and/or CRH-secreting pheochromocytomas. DATA SOURCE: A systematic search of PubMed/MEDLINE and Web of Science, identifying relevant reports published up to 10 February 2020. STUDY SELECTION: Original articles, including case reports and case series, reporting individual patient data from patients with ACTH- and/or CRH-secreting pheochromocytomas. DATA EXTRACTION: Information on sex, age, symptoms at presentation, comorbidities, biochemistry, imaging, histopathology, and outcomes was extracted. DATA SYNTHESIS: We identified 91 articles reporting on 99 cases of ACTH- and/or CRH-secreting pheochromocytomas (CRH-secreting n = 4). Median age at diagnosis was 49 years (interquartile range 38-59.5) with a 2:1 female to male ratio. Most patients presented with clinical Cushing syndrome (n = 79; 81%), hypertension (n = 87; 93%), and/or diabetes (n = 50; 54%). Blood pressure, glucose control, and biochemical parameters improved in the vast majority of patients postoperatively. Infections were the most common complication. Most cases (n = 70, 88%) with reported long-term outcome survived to publication (median follow-up 6 months). CONCLUSION: Ectopic ACTH- and/or CRH-secreting pheochromocytoma should be considered in patients presenting with ACTH-dependent Cushing syndrome and adrenal mass. Despite the challenge in diagnosis, patient outcomes appear favorable.
引用
- Elliott PF, Berhane T, Ragnarsson O, et al. Ectopic ACTH- and/or CRH-Producing Pheochromocytomas. J Clin Endocrinol Metab. 2021. PMID: 32710791. doi:10.1210/clinem/dgaa488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。